Identification of human parvovirus B19 among measles and rubella suspected patients from Cuba

Between September 2014 and December 2015, 298 sera from rash and fever patients from all over Cuba were investigated for specific IgM antibodies against measles, rubella, dengue, human parvovirus B19 (B19V) and human herpesvirus 6 (HHV6) using a commercial enzyme‐linked immunosorbent assay kits. B19...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical virology 2019-07, Vol.91 (7), p.1351-1354
Hauptverfasser: Ribas, María, Tejero, Yahisel, Cordero, Yanislet, Pérez, Daileny, Sausy, Aurélie, Muller, Claude P., Hübschen, Judith M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Between September 2014 and December 2015, 298 sera from rash and fever patients from all over Cuba were investigated for specific IgM antibodies against measles, rubella, dengue, human parvovirus B19 (B19V) and human herpesvirus 6 (HHV6) using a commercial enzyme‐linked immunosorbent assay kits. B19V IgM positive and equivocal samples were investigated by a polymerase chain reaction and genotyping. No measles, rubella or dengue cases were detected. HHV6‐IgM antibodies were confirmed in 5.7% and B19V‐IgM antibodies in 10.7% of the patients. A total of 31.3% of the B19V cases were between 5 and 9 years old and 34.4% were 20 years and older. The only B19V sequence obtained belonged to genotype 1a. Diagnosis was established for only 16% of the rash and fever patients, suggesting that other diseases such as Zika or Chikungunya may play a role. Highlights Our study confirmed the absence of measles and rubella in Cuba All 17 human herpesvirus 6 positive patients were children between 1 to 4 years 10.7% of the 298 patients were human parvovirus B19 IgM positive4.‐ First genotype data determined for human parvovirus B19 from Cuba
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.25444